235
Views
1
CrossRef citations to date
0
Altmetric
Review

Eyelid and Orbital Involvement in HIV Infection – An African Perspective

, FCOphth(SA), PhDORCID Icon & , FCOphth(SA), PhDORCID Icon
Pages 1022-1030 | Received 02 Aug 2019, Accepted 13 Dec 2019, Published online: 14 Feb 2020

References

  • UNAIDS, Fact Sheet-World AIDS Day 2018. Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2019; 2019. 2016–2021.
  • Unaids. UNIAIDS website; 2018, 6. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf%0Ahttp://www.unaids.org/en.
  • Holkar S, Mudhar HS, Jain A, et al. Regression of invasive conjunctival squamous carcinoma in an HIV-positive patient on antiretroviral therapy. Int J STD AIDS. 2005;16(12):782–783.doi:10.1258/095646205774988028.
  • van Niekerk JP. Editor’s choice SAMJ 2010. South African Med J. 2010;100(3):2010.
  • Pavan-Langston D. Herpes Zoster. antivirals and pain management. Ophthalmology. 2008;115(2SUPPL):13–20. doi:10.1016/j.ophtha.2007.10.012.
  • Van Dyk M, Meyer D Hutchinson’s sign as a marker of ocular involvement in HIV-positive patients with herpes zoster ophthalmicus. South African Med J. 2010;100(3). doi:10.7196/SAMJ.3191
  • Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal. 2005;352(22):2271–2284.
  • Center for Disease Control and Prevention Guidelines. National Center for Immunization and Respiratory Diseases. https://www.cdc.gov/vaccines/vpd/shingles/hcp/zostavax/recommendations.html. Published January 25, 2018. Accessed December 23, 2019.
  • Shafran SD. Live attenuated herpes zoster vaccine for HIV-infected adults. HIV Med. 2016;17(4):305–310. doi:10.1111/hiv.12311.
  • Cunningham ET, Margolis TP. Ocular Manifestations of HIV infection. N Engl J Med. 1998;339(4):236–244. doi:10.1056/NEJM199807233390406.
  • Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic infectious diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). https://www.cdc.gov/poxvirus/molluscum-contagiosum/. Published May 11, 2015. Accessed December 23, 2019.
  • Dohil MA, Lin P, Lee J, Lucky AW, Paller AS, Eichenfield LF. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. 2006;54(1):47–54. doi:10.1016/j.jaad.2005.08.035.
  • Brown J, Janniger CK, Schwartz RA, Silverberg NB. Childhood molluscum contagiosum. Int J Dermatol.2006;(45):93–99.
  • Sen S, Bhaumik P. Resolution of giant Molluscum contagiosum with antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2009;74(3):267. doi:10.4103/0378-6323.41382.
  • Ratnam I, Chiu C, Kandala N-B, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis. 2006;42(3):418–427. doi:10.1086/499356.
  • Lehloenya R, Meintjes G. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin. 2006;24(4):549–570. doi:10.1016/j.det.2006.06.007.
  • Kronish JW, Johnson TE, Gilberg SM, Corrent GF, McLeish WM, Scott KR. Orbital infections in patients with human immunodeficiency virus infection. Ophthalmology. 1996;103(9):1483–1492. doi:10.1016/S0161-6420(96)30479-X.
  • Manfredi R, Calza RCF. Epidemiology and microbiology of cellulitis and bacterial soft tissue infection during HIV disease: a 10-year survey. J Cutan Pathol. 2002;29(3):168–172. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L34478263%5Cnhttp://dx.doi.org/10.1034/j.1600-0560.2002.290307.x%5Cnhttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=03036987&id=doi:10.1034%2Fj.1600-0560.2002.290307.x&atitle=Epidem.
  • Moraes HV. Ocular manifestations of HIV/AIDS. Curr Opin Ophthalmol. 2002;13(6):397–403. doi:10.1097/00055735-200212000-00010.
  • Tsirouki T, Dastiridou AI, Ibánez Flores N, et al. Orbital cellulitis. Surv Ophthalmol. 2018;63(4):534–553.doi:10.1016/j.survophthal.2017.12.001.
  • Francis BA, Mui AL, Calonje D. Orbital streptococcal gangrene and AIDS. Orbit. 2003;20(3):243–248. doi:10.1076/orbi.20.3.243.2624.
  • Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science (80-). 1994; 266:1865–1869. doi:10.1126/science.7997879.
  • Uldrick TS, Whitby D. Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett. 2011;305(2):150–162. doi:10.1016/j.canlet.2011.02.006.
  • Radu O, Pantanowitz L. Resident short review Kaposi Sarcoma. Arch Pathol Lab Med. 2013;137:289–294. doi:10.5858/arpa.2012-0101-RS.
  • Malope BI, MacPhail P, Mbisa G, et al. No evidence of sexual transmission of Kaposi’s sarcoma herpes virus in a heterosexual South African population. Aids. 2008;22(4):519–526. doi:10.1097/QAD.0b013e3282f46582.
  • Klaskala W, Brayfield BP, Kankasa C, et al. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol. 2005;75(1):93–100.doi:10.1002/jmv.20242.
  • Campbell TB, Borok M, Ndemera B, et al. Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe. Clin Infect Dis. 2009;48(11):1601–1608.doi:10.1086/598978.
  • Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med. 2002. doi:10.1056/nejm199904083401402.
  • Mosam A, Shaik F, Uldrick TS, et al. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr. 2012;60:150–157. doi:10.1097/QAI.0b013e318251aedd.
  • Meyer D, Gooding C. Intralesional bleomycin as an adjunct therapeutic modality in eyelid and extraocular malignancies and tumors. Middle East Afr J Ophthalmol. 2015;22:410. doi:10.4103/0974-9233.167822.
  • Antle CM, White VA, Horsman DE, Rootman J. Large cell orbital lymphoma in a patient with acquired immune deficiency syndrome: case report and review. Ophthalmology. 1990;97(11):1494–1498. doi:10.1016/S0161-6420(90)32398-9.
  • Olsen TG, Holm F, Mikkelsen LH, et al. Orbital lymphoma—an international multicenter retrospective study. Am J Ophthalmol. 2019;199:44–57. doi:10.1016/j.ajo.2018.11.002.
  • Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15(4):264–271. doi:10.1080/09286580802077716.
  • Shah SU, Kerkar SP, Pazare AR. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Br J Ophthalmol. 2009;93(1):88–90. doi:10.1136/bjo.2008.149237.
  • Jing L, Deng J, Kozak I, et al. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in central South China. Ophthalmic Epidemiol. 2013. doi:10.3109/09286586.2013.789530.
  • Hessol NA, Whittemore H, Vittinghoff E, et al. Incidence of first and second primary cancers diagnosed among people with HIV, 1985–2013: a population-based, registry linkage study. Lancet HIV. 2018;5(11):e647–e655.doi:10.1016/S2352-3018(18)30179-6.
  • Morley AMS, Verity DH, Meligonis G, Rose GE. Orbital plasmablastic lymphomacomparison of a newly reported entity with diffuse large b-cell lymphoma of the orbit. Orbit. 2009;28(6):425–429. doi:10.3109/01676830903177427.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.